Loading…
Lobbying Spend
—
Filings
61
Firms Hired
3
Active Period
2009–2019
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Disclosing Foreign Influence Act
2018 · third_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to the scope of FARA, including H.R. 4170.
Client expense: — · Firm income: —
Matched citations: H.R. 4170
Disclosing Foreign Influence Act
2018 · second_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to lobbying disclosure reform, including H.R. 4170, S. 2039, and S. 2482.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 4170
Disclosing Foreign Influence Act
2018 · second_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to lobbying disclosure reform, including H.R. 4170, S. 2039, and S. 2482.
Client expense: — · Firm income: $20,000
Matched citations: S. 2039
Foreign Agents Registration Amendments Act of 2018
2018 · second_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to lobbying disclosure reform, including H.R. 4170, S. 2039, and S. 2482.
Client expense: — · Firm income: $20,000
Matched citations: S. 2482
Helping Families in Mental Health Crisis Act of 2016
2015 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to provisions in H.R. 6, the 21st Century Cures Act, and H.R. 2646, the Helping Families in Mental Health Crisis Act of 2015.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2646
21st Century Cures Act
2015 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to provisions in H.R. 6, the 21st Century Cures Act, and H.R. 2646, the Helping Families in Mental Health Crisis Act of 2015.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6
America's Affordable Health Choices Act of 2009
2010 · fourth_quarter · Firm: WINNING STRATEGIES WASHINGTON
Legislation that relates to orphan diseases as well as issues pertaining to small PHRMA companies. H.R. 3200, Health care reform legislation
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3200
America's Affordable Health Choices Act of 2009
2010 · fourth_quarter · Firm: WINNING STRATEGIES WASHINGTON
Legislation that relates to orphan diseases as well as issues pertaining to small PHRMA companies. H.R. 3200, Health care reform legislation
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3200
America's Affordable Health Choices Act of 2009
2010 · third_quarter · Firm: WINNING STRATEGIES WASHINGTON
Legislation that relates to orphan diseases as well as issues pertaining to small PHRMA companies. H.R. 3200, Health care reform legislation
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3200
America's Affordable Health Choices Act of 2009
2010 · third_quarter · Firm: WINNING STRATEGIES WASHINGTON
Legislation that relates to orphan diseases as well as issues pertaining to small PHRMA companies. H.R. 3200, Health care reform legislation
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3200
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · second_quarter · Firm: POLICY IMPACT COMMUNICATIONS, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $20,000
Matched citations: HR 1298
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · second_quarter · Firm: POLICY IMPACT COMMUNICATIONS, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $20,000
Matched citations: HR 1427
Pathway for Biosimilars Act
2010 · second_quarter · Firm: POLICY IMPACT COMMUNICATIONS, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $20,000
Matched citations: HR 1548
America's Affordable Health Choices Act of 2009
2010 · second_quarter · Firm: POLICY IMPACT COMMUNICATIONS, INC.
HR 3200 -- Access to and coverage of Specialty Pharmaceuticals, Removal of patient life time caps and special tiering of copayments. S. 301 Physician payments and transparency, preemption of state law. America's Heathy Future Act of 2009
Client expense: — · Firm income: $20,000
Matched citations: HR 3200
Physician Payments Sunshine Act of 2009
2010 · second_quarter · Firm: POLICY IMPACT COMMUNICATIONS, INC.
HR 3200 -- Access to and coverage of Specialty Pharmaceuticals, Removal of patient life time caps and special tiering of copayments. S. 301 Physician payments and transparency, preemption of state law. America's Heathy Future Act of 2009
Client expense: — · Firm income: $20,000
Matched citations: S. 301
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · second_quarter · Firm: POLICY IMPACT COMMUNICATIONS, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $20,000
Matched citations: S. 525
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · second_quarter · Firm: POLICY IMPACT COMMUNICATIONS, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $20,000
Matched citations: S. 726
America's Affordable Health Choices Act of 2009
2010 · second_quarter · Firm: WINNING STRATEGIES WASHINGTON
Legislation that relates to orphan diseases as well as issues pertaining to small PHRMA companies. H.R. 3200, Health care reform legislation
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3200
America's Affordable Health Choices Act of 2009
2010 · second_quarter · Firm: WINNING STRATEGIES WASHINGTON
Legislation that relates to orphan diseases as well as issues pertaining to small PHRMA companies. H.R. 3200, Health care reform legislation
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3200
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · first_quarter · Firm: POLICY IMPACT COMMUNICATIONS, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $30,000
Matched citations: HR 1298
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Firm: POLICY IMPACT COMMUNICATIONS, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $30,000
Matched citations: HR 1427
Pathway for Biosimilars Act
2010 · first_quarter · Firm: POLICY IMPACT COMMUNICATIONS, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $30,000
Matched citations: HR 1548
America's Affordable Health Choices Act of 2009
2010 · first_quarter · Firm: POLICY IMPACT COMMUNICATIONS, INC.
HR 3200 -- Access to and coverage of Specialty Pharmaceuticals, Removal of patient life time caps and special tiering of copayments. S. 301 Physician payments and transparency, preemption of state law. America's Heathy Future Act of 2009
Client expense: — · Firm income: $30,000
Matched citations: HR 3200
Physician Payments Sunshine Act of 2009
2010 · first_quarter · Firm: POLICY IMPACT COMMUNICATIONS, INC.
HR 3200 -- Access to and coverage of Specialty Pharmaceuticals, Removal of patient life time caps and special tiering of copayments. S. 301 Physician payments and transparency, preemption of state law. America's Heathy Future Act of 2009
Client expense: — · Firm income: $30,000
Matched citations: S. 301
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · first_quarter · Firm: POLICY IMPACT COMMUNICATIONS, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $30,000
Matched citations: S. 525
Source: Senate LDA